Clinical trial
Phase II Study of a Non-Steroidal Novel Treatment for Scalp Psoriasis
NCT01368887 is registered in ClinicalTrials.gov with DermiPsor, Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of a Non-Steroidal Novel Treatment for Scalp Psoriasis
- Lead sponsor
- DermiPsor, Ltd.
- Phase
- Phase 2
- Overall status
- Suspended
- Start date
- April 30, 2013
- Completion date
- April 30, 2014
- Enrollment
- 160 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.